Anti-CD20 therapeutic compositions and methods
Details for Australian Patent Application No. 2008266952 (hide)
International Classifications
Event Publications
28 January 2010 PCT application entered the National Phase
PCT publication WO2008/156713 Priority application(s): WO2008/156713
11 March 2010 Alteration of Name
The name of the applicant has been altered to Wyeth LLC; Trubion Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008266954-CETP inhibitors derived from benzoxazole arylamides
2008266951-Antibodies to human programmed death receptor PD-1
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser